Current methods most commonly used for genetically modifying hMSCs are based on random transgene integration; however, the uncertainty of the integration site brings problems.
The strategy most commonly used when generating genetically modified plants that are commercially relevant is to introduce a genetic construct that either confers some kind of advantage when it comes to farming/storage or increases the nutritional quality of the end product.
Currently, in order to increase the plant resistance to the pathogenic infection, genetic engineering is the most commonly used tool to produce genetically modified organisms (GMOs).
The identification of genes and proteins involved in pathogenesis has most commonly relied on analyzing genetic variations between strains or by directly isolating then genetically and biochemically characterizing specific mutants [ 9- 12].
Yet, this strain is one of the most commonly used for creating and maintaining genetically modified (GM) lines.
Among various systems to produce heterologous proteins for structural and functional studies, protein expression in Escherichia coli is the most commonly used system because it is genetically simple, inexpensive for producing large quantities of proteins and permits the isotopic or heavy atom labelling of proteins that is necessary for some structural methods.
As human embryos are far more genetically diverse than most commonly used mouse strains, the derivation of human ES and iPS cell lines may require embryo tailored culture conditions.
Genetically encoded sensors are most commonly incorporated into cells as plasmid DNA.
For C. parvum, C. hominis, and some genetically related species, the most commonly used marker for subtyping is the 60-kDa glycoprotein gene (gp60, also called gp40/15).
Some 90percentt of corn and soybeans are grown from genetically engineered seeds, and then sprayed most commonly with glyphosate, which is designed to kill all plants other than the corn or soy.
